Merck & Co. (MRK)
(Delayed Data from NYSE)
$85.98 USD
-0.30 (-0.35%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $86.10 +0.12 (0.14%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MRK 85.98 -0.30(-0.35%)
Will MRK be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for MRK based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for MRK
MRK Beats Q3 Earnings Estimates, Narrows 2025 Sales View, Stock Down
Merck (MRK) Reports Q3 Earnings: What Key Metrics Have to Say
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merck (MRK) Q3 Earnings and Revenues Beat Estimates
Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings?
Buy, Sell or Hold MRK Stock Ahead of Q3 Earnings? Things to Know
Other News for MRK
Notable healthcare headlines for the week: UNH, Eli Lilly and Merck in focus
Top 10 High-Yield Dividend Stocks For November 2025
Earnings Scorecard: 24 out of 25 healthcare firms deliver EPS wins this week
MRK forms Non-ADX 1,2,3,4 Bullish on October 31
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (Nov. 2025)